Trial
NCT00318474
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Collaborators
—
Condition
IgA Nephropathy
Intervention
Mycophenolate Mofetil (MMF)
Why stopped
DSMB recommended stopping the trial because of lack of effect.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-07